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SUPPLEMENTARY TABLE: Peripheral blood cell counts in breast cancer patients before and after the first course of AFTV vaccination.
Breast cancer patients (without bone metastasis) have been submitted for treatment with AFTV. After surgery, chemotherapy, and sufficient time to recover their immunological function, we quantified T-cell populations in the peripheral blood of 39 patients before and after the AFTV treatment. Among them, 32 patients exhibited a change in the delayed-type hypersensitivity response from negative to positive to the fixed carcinoma tissue fragments which were not including any immune adjuvant. We examined change of peripheral blood T-cell population in the 32 patients just before the first injection of AFTV and 2 weeks after the 
